FIA
RLAY icon

FNY Investment Advisers’s Relay Therapeutics RLAY Stock Holding History

FNY Investment Advisers’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,000
Closed -$49K – 1025
2026
Q1 		$49K Hold
5,000
– – 0.02% 362
2025
Q4 		$42K Sell
5,000
-5,000
-50% -$35.7K 0.01% 466
2025
Q3 		$52K Hold
10,000
– – 0.02% 488
2025
Q2 		$34K Buy
10,000
+5,000
+100% +$14.9K 0.01% 479
2025
Q1 		$13K Buy
+5,000
New +$19.6K 0.01% 457

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

FNY Investment Advisers's RLAY Position: Q2 2026 in Review

FNY Investment Advisers sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 5,000 shares — an estimated $49K sold.

FNY Investment Advisers first reported a position in RLAY in Q1 2025 and held it in 5 quarters. The position peaked at $52K in Q3 2025. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • FNY Investment Advisers reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 5,000 Relay Therapeutics shares in Q2 2026, an estimated $49K.
  • FNY Investment Advisers first reported a position in Relay Therapeutics in Q1 2025 and held it in 5 quarters.
  • FNY Investment Advisers's Relay Therapeutics position peaked at $52K in Q3 2025.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.